LYPHF
Price
$0.27
Change
+$0.01 (+3.85%)
Updated
Apr 11 closing price
Capitalization
1.76B
SNYNF
Price
$98.33
Change
+$1.68 (+1.74%)
Updated
Jul 3 closing price
Capitalization
134.16B
Interact to see
Advertisement

LYPHF vs SNYNF

Header iconLYPHF vs SNYNF Comparison
Open Charts LYPHF vs SNYNFBanner chart's image
Luye Pharma Group
Price$0.27
Change+$0.01 (+3.85%)
Volume$3.73K
Capitalization1.76B
Sanofi
Price$98.33
Change+$1.68 (+1.74%)
Volume$327
Capitalization134.16B
LYPHF vs SNYNF Comparison Chart in %
Loading...
LYPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYPHF vs. SNYNF commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYPHF is a Hold and SNYNF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (LYPHF: $0.27 vs. SNYNF: $98.33)
Brand notoriety: LYPHF and SNYNF are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: LYPHF: 100% vs. SNYNF: 1%
Market capitalization -- LYPHF: $1.76B vs. SNYNF: $134.16B
LYPHF [@Pharmaceuticals: Major] is valued at $1.76B. SNYNF’s [@Pharmaceuticals: Major] market capitalization is $134.16B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYPHF’s FA Score shows that 0 FA rating(s) are green whileSNYNF’s FA Score has 1 green FA rating(s).

  • LYPHF’s FA Score: 0 green, 5 red.
  • SNYNF’s FA Score: 1 green, 4 red.
According to our system of comparison, SNYNF is a better buy in the long-term than LYPHF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYPHF’s TA Score shows that 2 TA indicator(s) are bullish while SNYNF’s TA Score has 4 bullish TA indicator(s).

  • LYPHF’s TA Score: 2 bullish, 0 bearish.
  • SNYNF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, both LYPHF and SNYNF are a good buy in the short-term.

Price Growth

LYPHF (@Pharmaceuticals: Major) experienced а 0.00% price change this week, while SNYNF (@Pharmaceuticals: Major) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.05%. For the same industry, the average monthly price growth was +0.58%, and the average quarterly price growth was +9.03%.

Industries' Descriptions

@Pharmaceuticals: Major (+1.05% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SNYNF($134B) has a higher market cap than LYPHF($1.76B). LYPHF has higher P/E ratio than SNYNF: LYPHF (19.23) vs SNYNF (14.04). SNYNF YTD gains are higher at: 3.398 vs. LYPHF (-22.025). SNYNF has higher annual earnings (EBITDA): 13.8B vs. LYPHF (907M). SNYNF has more cash in the bank: 7.99B vs. LYPHF (5.51B). LYPHF has less debt than SNYNF: LYPHF (9.49B) vs SNYNF (21B). SNYNF has higher revenues than LYPHF: SNYNF (46.1B) vs LYPHF (5.2B).
LYPHFSNYNFLYPHF / SNYNF
Capitalization1.76B134B1%
EBITDA907M13.8B7%
Gain YTD-22.0253.398-648%
P/E Ratio19.2314.04137%
Revenue5.2B46.1B11%
Total Cash5.51B7.99B69%
Total Debt9.49B21B45%
FUNDAMENTALS RATINGS
SNYNF: Fundamental Ratings
SNYNF
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
87
SMR RATING
1..100
75
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
89
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYPHFSNYNF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 5 days ago
46%
Momentum
ODDS (%)
N/A
Bullish Trend 5 days ago
46%
MACD
ODDS (%)
N/A
Bullish Trend 5 days ago
55%
TrendWeek
ODDS (%)
Bullish Trend 5 days ago
5%
Bullish Trend 5 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 5 days ago
5%
Bullish Trend 5 days ago
48%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
48%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
51%
View a ticker or compare two or three
Interact to see
Advertisement
LYPHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SNYNF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALGS7.840.53
+7.25%
Aligos Therapeutics Inc
GPRE6.980.45
+6.89%
Green Plains
GTLS173.635.48
+3.26%
Chart Industries
JPM296.005.40
+1.86%
JPMorgan Chase & Co
EBTC39.64N/A
N/A
Enterprise Bancorp

LYPHF and

Correlation & Price change

A.I.dvisor tells us that LYPHF and MRK have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYPHF and MRK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYPHF
1D Price
Change %
LYPHF100%
N/A
MRK - LYPHF
20%
Poorly correlated
-1.77%
OGN - LYPHF
13%
Poorly correlated
-1.87%
SNYNF - LYPHF
2%
Poorly correlated
+1.74%
SCLX - LYPHF
2%
Poorly correlated
+1.92%
CSWYF - LYPHF
1%
Poorly correlated
N/A
More

SNYNF and

Correlation & Price change

A.I.dvisor tells us that SNYNF and NVSEF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SNYNF and NVSEF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SNYNF
1D Price
Change %
SNYNF100%
+1.74%
NVSEF - SNYNF
27%
Poorly correlated
-3.76%
BIIB - SNYNF
21%
Poorly correlated
-0.24%
OGN - SNYNF
17%
Poorly correlated
-1.87%
SCLX - SNYNF
7%
Poorly correlated
+1.92%
MIRA - SNYNF
4%
Poorly correlated
-3.23%
More